|
Real-time Estimate
Cboe BZX
12:32:52 08/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 24.17 USD | -0.45% |
|
-5.34% | +1.89% |
| 23/09 | Arcus Biosciences, Inc. Announces New Data for Casdatifan as Treatment for Kidney Cancer Across Multiple Lines of Therapy | CI |
| 16/09 | TD Cowen Initiates Arcus Biosciences at Buy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.09B | - | ||||
| 74.69B | |||||
| 58.81B | |||||
| 48.45B | |||||
| 42.84B | - | - | - | - | - |
| 42.79B |
Select your edition
All financial news and data tailored to specific country editions
